The ratio of NE to α1-antitrypsin (108), plasma concentration of PR3 and NE (109), neutrophil-to-lymphocyte ratio (110), serum levels of LCN2 (111), NETs (68), and MPO (112) significantly increase in patients with NAFLD. The gene discussed is PRTN3; the disease is metabolic dysfunction-associated steatotic liver disease.